Market Update
In a significant development, Revolution Medicines has drawn attention as its biotechnology stock surged by 13% following the release of promising test results for Daraxonrasib, a new treatment aimed at pancreatic cancer. With these encouraging findings, the company plans to initiate a Phase 3 trial in the fourth quarter.
On a different note, Delta Air Lines saw its shares tumble more than 3% after reiterating its third-quarter revenue guidance, forecasting earnings between $1.25 and $1.75 per share.
In positive news, Centene’s shares rose by 12% as the health insurance provider reaffirmed its annual revenue outlook from July. They indicated that quality ratings for their Medicare plans are meeting expectations.
Opendoor Technologies, considered a meme stock, experienced a remarkable 65% increase after appointing Kaz Nejatian, a Shopify executive, as the new CEO. This followed the resignation of former CEO Carrie Wheeler amid pressure from investors.
Meanwhile, Oxford Industries, which owns brands like Tommy Bahama and Lilly Pulitzer, jumped 22% after their second-quarter earnings surpassed forecasts. They also noted that the impact of tariffs would be less than what was initially predicted earlier this year.
Shares of Alibaba, the Chinese e-commerce giant, rose by 4% after the company announced plans to issue a $3.2 billion coupon convertible senior note by 2032.
Oracle demonstrated strong performance as well, with a 2.6% increase following a record-breaking day where its stock surged nearly 36%, marking the highest single-day gain since 1992 after a promising revenue report and positive forecasts related to artificial intelligence. Oracle’s current market capitalization stands at $922 billion.
Kroger, the grocery retail chain, saw its shares climb 2% despite mixed financial results. The company reported adjusted second-quarter earnings of $1.04 per share, which surpassed analysts’ expectations of 99 cents, although its revenue of $33.94 billion fell short of the $34.1 billion consensus estimate.
Celsius Holdings, known for its energy drinks, gained 2.7% following an endorsement from Goldman Sachs, who noted the brand’s rapid growth in the marketplace.
Chewy, the online pet retailer, saw its stock rise by 2% after a sharp decline of 16% the previous day. Despite reporting a significant year-over-year revenue drop, the company received an upgrade from Deutsche Bank and indicated that it is still on track for meaningful profit growth, looking ahead to an acceleration in revenue by 2026.
Lastly, shares of Thermo Fisher Scientific climbed 2% following a favorable upgrade from Barclays, which highlighted the stock’s improved appeal in the market. In contrast, Synopsys, which had plummeted 35% before, rebounded with a 10% increase after reporting revenues of $3.39 per share against a consensus estimate that was slightly higher.
